Tumour-agnostic kinase inhibitors
J
Jacob J. Adashek
M
Mina Nikanjam
(Division of Hematology‐Oncology University of California San Diego La Jolla California USA)
R
Razelle Kurzrock
(Division of Hematology and Medical Oncology Medical College of Wisconsin Cancer Center Milwaukee Wisconsin USA)
Article Details
Journal
Nature Reviews Drug Discovery
Volume / Issue
Vol. 24, Issue 7
Published
July 01, 2025
Pages
504-520
ISSN
1474-1776
Publisher
Springer Science and Business Media LLC
Journal Info
Nature Reviews Drug Discovery
Springer Science and Business Media LLC
ISSN: 1474-1776 Q1 Medicine
Authors (3)
J
Jacob J. Adashek
M
Mina Nikanjam
Division of Hematology‐Oncology University of California San Diego La Jolla California USA
R
Razelle Kurzrock
Division of Hematology and Medical Oncology Medical College of Wisconsin Cancer Center Milwaukee Wisconsin USA
Related Articles from this Journal
Can multispecific biologics break the efficacy ceiling?
Asher Mullard
Jul 2026
10.1038/d41573-026-00106-5
Novel drug targets in 2025
Sorin Avram, Liliana Halip et al.
Jul 2026
10.1038/d41573-026-00102-9
The unglamourous AI wins that are quietly transforming drug discovery and development
Asher Mullard
Jul 2026
10.1038/d41573-026-00099-1
Upcoming FDA approval decisions in Q3 2026
Swetha Kota
Jul 2026
10.1038/d41573-026-00103-8
Antiviral peptide nabs FDA approval for hepatitis delta virus infection
Asher Mullard
Jul 2026
10.1038/d41573-026-00101-w